Company: LNAI
Filing Date: 2025-03-06
Form Type: 425
Source: 0001731122-25-000356
Chunk: 0

Company: Lunai Bioworks Inc.
Filing Date: 2025-03-06
Form: 425
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 28, 2025

RENOVARO INC.

(Exact name of registrant as specified in its charter)</div>

| Delaware                                |     | 001-38758   |     | 45-2259340                  |
| (State                                  
 or other jurisdiction of incorporation) |     | -Commission 
 File Number |     | -IRS                        
 Employer Identification No. |

<div align='center'>2080 Century Park East, Suite 906, Los Angeles, CA 90067

(Address of principal executive offices and zip code)</div>

| +1                                     
 (305) 918-1980                         |
| (Registrant’s                          
 telephone number, including area code) |

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

| ☒ | Written                                                                               
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)         |
| ☐ | Soliciting                                                                            
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)           |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement                                                                      
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |

Securities registered pursuant to Section 12(b) of the Act:

| Title                              
 of each class                      |     | Trading   
 Symbol(s) |     | Name                                 
 of Each Exchange on Which Registered |
| Common                             
 Stock, par value $0.0001 per share |     | RENB      |     | The                                  
 Nasdaq Stock Market LLC              |

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange